> Investors > 2016 News Releases

2016 News Releases

Keyword Search
 
Category
Year   
DateTitle 
12/01/16ACETO Board of Directors Declares Quarterly Cash Dividend
PORT WASHINGTON, N.Y., Dec. 01, 2016 (GLOBE NEWSWIRE) -- ACETO Corporation (NASDAQ:ACET), an international company engaged in the development, marketing, sale and distribution of Human Health products, Pharmaceutical Ingredients and Performance Chemicals, today announced that its Board of Directors has declared a regular quarterly dividend of $0.065 per common share.  This quarterly cash dividend will be distributed on December 22, 2016 to shareholders of record as of December 12, 2016. ABO... 
Printer Friendly Version
11/17/16ACETO Subsidiary, Rising Pharmaceuticals, to Launch Erythromycin and Benzoyl Peroxide Topical Gel USP, 3%/5%
PORT WASHINGTON, N.Y., Nov. 17, 2016 (GLOBE NEWSWIRE) -- ACETO Corporation (NASDAQ:ACET), an international company engaged in the development, marketing, sale and distribution of Human Health products, Pharmaceutical Ingredients and Performance Chemicals, today announced that Rising Pharmaceuticals, Inc., its finished dosage form generics subsidiary, is launching Erythromycin and Benzoyl Peroxide Topical Gel USP, 3%/5% an FDA-approved generic version of Valeant International’s Benzamycin® Gel,... 
Printer Friendly Version
11/14/16ACETO Subsidiary, Rising Pharmaceuticals, to Launch Oxybutynin Chloride Extended-Release Tablets, USP
PORT WASHINGTON, N.Y., Nov. 14, 2016 (GLOBE NEWSWIRE) -- ACETO Corporation (NASDAQ:ACET), an international company engaged in the development, marketing, sale and distribution of Human Health products, Pharmaceutical Ingredients and Performance Chemicals, today announced that Rising Pharmaceuticals, Inc., its finished dosage form generics subsidiary, is launching Oxybutynin Chloride Extended-Release Tablets, USP, an FDA-approved generic version of Janssen Pharmaceuticals, Inc.’s Ditropan XL Ta... 
Printer Friendly Version
11/02/16ACETO Corporation to Hold Conference Call on November 3, 2016 at 9:00 a.m. ET
Conference Call Previously Scheduled on November 4 at 9:00 a.m. ET PORT WASHINGTON, N.Y., Nov. 02, 2016 (GLOBE NEWSWIRE) -- ACETO Corporation (NASDAQ:ACET), an international company engaged in the development, marketing, sales and distribution of Human Health products, Pharmaceutical Ingredients and Performance Chemicals, announced today that the date of the Company’s conference call to discuss the operating and financial results for the first quarter of fiscal 2017, originally scheduled on N... 
Printer Friendly Version
11/02/16ACETO Reports Fiscal 2017 First Quarter Results
Separately Company Announces Acquisition of Generic Products and Related Assets of Citron Pharma Management to Host Conference Call on November 3, 2016 at 9:00 a.m. ET PORT WASHINGTON, N.Y., Nov. 02, 2016 (GLOBE NEWSWIRE) -- ACETO Corporation (Nasdaq:ACET), focused on the global marketing, sale and distribution of Human Health products, Pharmaceutical Ingredients and Performance Chemicals, announced today financial results for the first quarter of fiscal 2017 ended September 30, 2016. First... 
Printer Friendly Version
11/02/16ACETO to Acquire Generic Products and Related Assets of Citron Pharma and Lucid Pharma
Transaction Significantly Enlarges ACETO’s Finished Dosage Generic Drug Business Combines complementary asset-light business models, products and partners Adds significant value of 47 commercialized generic drug products, and 31 approved and yet-to-be launched products Adds 33 pipeline projects; 29 ANDAs to be owned by Rising Pharmaceuticals Adds scale to Rising Pharmaceuticals Expected to be accretive to GAAP EPS within 12 months after closing and accretive to non-GAAP Adjusted... 
Printer Friendly Version
10/21/16ACETO Corporation Schedules First Quarter Fiscal 2017 Financial Results News Release and Conference Call
PORT WASHINGTON, N.Y., Oct. 21, 2016 (GLOBE NEWSWIRE) -- ACETO Corporation (NASDAQ:ACET), an international company engaged in the development, marketing, sales and distribution of Human Health products, Pharmaceutical Ingredients and Performance Chemicals, will issue its financial results of operations for the first quarter of fiscal 2017 ended September 30, 2016 after the stock market close on Thursday, November 3, 2016. Management will host a conference call to discuss the operating and f... 
Printer Friendly Version
09/16/16ACETO Subsidiary, Rising Pharmaceuticals, to Launch Fluocinolone Acetonide OTIC Oil, 0.01%
PORT WASHINGTON, N.Y., Sept. 16, 2016 (GLOBE NEWSWIRE) -- ACETO Corporation (NASDAQ:ACET), an international company engaged in the development, marketing, sale and distribution of Human Health products, Pharmaceutical Ingredients and Performance Chemicals, today announced that Rising Pharmaceuticals, Inc., its finished dosage form generics subsidiary, is launching Fluocinolone Acetonide OTIC Oil, 0.01%, an FDA approved generic version of Hill Dermaceuticals Inc.’s DermOtic®. According to IM... 
Printer Friendly Version
09/06/16ACETO Appoints William C. Kennally, III to the Board of Directors
PORT WASHINGTON, N.Y., Sept. 06, 2016 (GLOBE NEWSWIRE) -- ACETO Corporation (Nasdaq:ACET), an international company engaged in the development, marketing, sale and distribution of Human Health products, Pharmaceutical Ingredients and Performance Chemicals, announced that it has appointed William C. Kennally, III, 61 years old, to its Board of Directors, effective September 6, 2016. Chairman of the Board, Albert Eilender, commented, “We are pleased to welcome Bill to the ACETO board.  He has... 
Printer Friendly Version
09/06/16ACETO to Present at the Morgan Stanley 2016 Global Healthcare Conference
PORT WASHINGTON, N.Y., Sept. 06, 2016 (GLOBE NEWSWIRE) -- ACETO Corporation (NASDAQ:ACET), an international company engaged in the development, marketing, sale and distribution of Human Health products, Pharmaceutical Ingredients and Performance Chemicals, today announced that Sal Guccione, President and CEO, will present at the Morgan Stanley 2016 Global Healthcare Conference on Tuesday, September 13, 2016 at 4:05 PM ET. A webcast of the presentation will be available under Events and Pres... 
Printer Friendly Version
08/25/16ACETO Reports Fiscal 2016 Fourth Quarter and Record Full Year Results
PORT WASHINGTON, N.Y., Aug. 25, 2016 (GLOBE NEWSWIRE) -- ACETO Corporation (Nasdaq:ACET), an international company engaged in the development, marketing, sale and distribution of Human Health products, Pharmaceutical Ingredients and Performance Chemicals, announced today financial results for the fourth quarter and fiscal year ended June 30, 2016. Fiscal 2016 versus Fiscal 2015 Net sales of $558.5 million versus $547.0 million, a 2.1% increase Gross profit of $142.8 million versus $... 
Printer Friendly Version
08/25/16ACETO Board of Directors Increases Quarterly Cash Dividend by 8.3%
PORT WASHINGTON, N.Y., Aug. 25, 2016 (GLOBE NEWSWIRE) -- ACETO Corporation (NASDAQ:ACET), an international company engaged in the development, marketing, sale and distribution of Human Health products, Pharmaceutical Ingredients and Performance Chemicals, today announced that its Board of Directors has increased its regular quarterly dividend to $0.065 per common share.  This quarterly cash dividend will be distributed on September 20, 2016 to shareholders of record as of September 9, 2016. ... 
Printer Friendly Version
08/23/16ACETO Subsidiary, Rising Pharmaceuticals, to launch Fluocinolone Acetonide Body Oil, 0.01%, and Fluocinolone Acetonide Scalp Oil, 0.01%
PORT WASHINGTON, N.Y., Aug. 23, 2016 (GLOBE NEWSWIRE) -- ACETO Corporation (NASDAQ:ACET), an international company engaged in the development, marketing, sale and distribution of Human Health products, Pharmaceutical Ingredients and Performance Chemicals, announced that Rising Pharmaceuticals, Inc., its finished dosage form generics subsidiary, has launched two new products, Fluocinolone Acetonide Body Oil, 0.01%, an FDA approved generic version of Derma-Smoothe/FS® Body Oil, and Fluocinolone ... 
Printer Friendly Version
08/12/16ACETO Corporation Schedules Fourth Quarter & Fiscal 2016 Financial Results News Release and Conference Call
PORT WASHINGTON, N.Y., Aug. 12, 2016 (GLOBE NEWSWIRE) -- ACETO Corporation (NASDAQ:ACET), an international company engaged in the development, marketing, sales and distribution of Human Health products, Pharmaceutical Ingredients and Performance Chemicals, will issue its financial results of operations for the fourth quarter of fiscal 2016 and the full fiscal year ended June 30, 2016 after the stock market close on Thursday, August 25, 2016. Management will host a conference call to discuss... 
Printer Friendly Version
07/18/16ACETO Names Walter Kaczmarek III Chief Operating Officer
PORT WASHINGTON, N.Y., July 18, 2016 (GLOBE NEWSWIRE) -- ACETO Corporation (NASDAQ:ACET), a global leader in the marketing, sale and distribution of  products for Human Health, Pharmaceutical Ingredients and Performance Chemicals, today announced that it has named Walter J. Kaczmarek III  its Chief Operating Officer effective August 1, 2016.  Mr. Kaczmarek will assume responsibility for managing day-to-day operations at ACETO’s three business segments, reporting to Salvatore Guccione, Chief... 
Printer Friendly Version
05/23/16ACETO to Present in June Conferences
PORT WASHINGTON, N.Y., May 23, 2016 (GLOBE NEWSWIRE) -- ACETO Corporation (NASDAQ:ACET), an international company engaged in the marketing, sale and distribution of Human Health products, Pharmaceutical Ingredients and Performance Chemicals, today announced it will participate in two investor conferences taking place in June. 13th Annual Craig-Hallum Institutional Investor Conference in Minneapolis, MN on June 1.  Salvatore Guccione, President and CEO will host one-on-one meetings throu... 
Printer Friendly Version
05/05/16ACETO Reports Fiscal 2016 Third Quarter Results
PORT WASHINGTON, N.Y., May 05, 2016 (GLOBE NEWSWIRE) -- ACETO Corporation (Nasdaq:ACET), an international company engaged in the marketing, sale and distribution of Human Health products, Pharmaceutical Ingredients and Performance Chemicals, announced today financial results for the third quarter of fiscal 2016 ended March 31, 2016. Third Quarter Fiscal 2016 versus Third Quarter Fiscal 2015 Net sales of $157.9 million versus $145.8 million, an 8.3% increase Gross profit of $38.3 mil... 
Printer Friendly Version
05/05/16ACETO Board of Directors Declares Quarterly Cash Dividend
PORT WASHINGTON, N.Y., May 05, 2016 (GLOBE NEWSWIRE) -- ACETO Corporation (NASDAQ:ACET), an international company engaged in the marketing, sale and distribution of Human Health products, Pharmaceutical Ingredients and Performance Chemicals, today announced that its Board of Directors has declared a regular quarterly dividend of $0.06 per common share.  This quarterly cash dividend will be distributed on June 24, 2016 to shareholders of record as of June 9, 2016. ABOUT ACETO ACETO Corporat... 
Printer Friendly Version
04/21/16ACETO Corporation Schedules Third Quarter & Fiscal 2016 Financial Results News Release and Conference Call
PORT WASHINGTON, N.Y., April 21, 2016 (GLOBE NEWSWIRE) -- ACETO Corporation (NASDAQ:ACET), an international company engaged in the marketing, sales and distribution of Human Health products, Pharmaceutical Ingredients and Performance Chemicals, will issue its financial results of operations for the third quarter of fiscal 2016 ended March 31, 2016 after the stock market close on Thursday, May 5, 2016. Management will host a conference call to discuss the operating and financial results at 9... 
Printer Friendly Version
04/07/16ACETO to Present at the Needham & Company Healthcare Conference
PORT WASHINGTON, N.Y., April 07, 2016 (GLOBE NEWSWIRE) -- ACETO Corporation (NASDAQ:ACET), an international company engaged in the marketing, sale and distribution of Human Health products, Pharmaceutical Ingredients and Performance Chemicals, today announced that Salvatore Guccione, President and CEO, will present at the Needham & Company Healthcare Conference on April 12, 2016 at 5:00 pm ET at the Westin New York Grand Central Hotel. A webcast of the presentation will be available und... 
Printer Friendly Version
03/23/16ACETO Subsidiary, Rising Pharmaceuticals, to Launch Lithium Carbonate Extended-release Tablets and Metronidazole Tablets
PORT WASHINGTON, N.Y., March 23, 2016 (GLOBE NEWSWIRE) -- ACETO Corporation (NASDAQ:ACET), an international company engaged in the marketing, sale and distribution of Human Health products, Pharmaceutical Ingredients and Performance Chemicals, today announced that Rising Pharmaceuticals, Inc., its finished dosage form generics subsidiary, is launching Lithium Carbonate Extended-release Tablets, 300mg, an FDA approved generic version of ANI Pharmaceutical Inc.’s Lithobid®, and Metronidazole Tab... 
Printer Friendly Version
02/04/16ACETO Reports Fiscal 2016 Second Quarter Results
PORT WASHINGTON, N.Y., Feb. 04, 2016 (GLOBE NEWSWIRE) -- ACETO Corporation (Nasdaq:ACET), an international company engaged in the marketing, sale and distribution of Human Health products, Pharmaceutical Ingredients and Performance Chemicals, announced today financial results for the second quarter of fiscal 2016 ended December 31, 2015. Second Quarter Fiscal 2016 versus Second Quarter Fiscal 2015 Net sales of $131.7 million versus $123.8 million, a 6.4% increase Gross profit of $35... 
Printer Friendly Version
02/04/16ACETO Board of Directors Declares Quarterly Cash Dividend
PORT WASHINGTON, N.Y., Feb. 04, 2016 (GLOBE NEWSWIRE) -- ACETO Corporation (NASDAQ:ACET), an international company engaged in the marketing, sale and distribution of Human Health products, Pharmaceutical Ingredients and Performance Chemicals, today announced that its Board of Directors has declared a regular quarterly dividend of $0.06 per common share.  This quarterly cash dividend will be distributed on March 25, 2016 to shareholders of record as of March 11, 2016. ABOUT ACETO ACETO Corp... 
Printer Friendly Version
01/27/16ACETO Corporation Schedules Second Quarter & Fiscal 2016 Financial Results News Release and Conference Call
PORT WASHINGTON, N.Y., Jan. 27, 2016 (GLOBE NEWSWIRE) -- ACETO Corporation (NASDAQ:ACET), an international company engaged in the marketing, sales and distribution of Human Health products, Pharmaceutical Ingredients and Performance Chemicals, will issue its financial results of operations for the second quarter of fiscal 2016 ended December 31, 2015 after the stock market close on Thursday, February 4, 2016. Management will host a conference call to discuss the operating and financial resu... 
Printer Friendly Version
01/25/16ACETO Subsidiary, Rising Pharmaceuticals, to Launch Zolmitriptan Tablets
PORT WASHINGTON, N.Y., Jan. 25, 2016 (GLOBE NEWSWIRE) -- ACETO Corporation (NASDAQ:ACET), an international company engaged in the marketing, sale and distribution of Human Health products, Pharmaceutical Ingredients and Performance Chemicals, today announced that Rising Pharmaceuticals, Inc., its finished dosage form generics subsidiary, is launching Zolmitriptan Tablets, 2.5mg and 5mg, an FDA approved generic version of IPR Pharmaceuticals, Inc.’s Zomig®.   According to IMS Health data, U.... 
Printer Friendly Version

top